Logistics · Packaging

Packaging and labelling a pharmaceutical export shipment

By LNJC· · 6 min read

WHO Technical Report Series No. 1025, Annex 7, asks that shipment containers protect the product and are labelled with, for example, handling and storage conditions, precautions, contents, source and safety symbols. Product, batch and container identity should be maintained at all times, labels should remain legible, and products in transit must be accompanied by appropriate documentation.

Container labelshandling and storage conditions, precautions, contents and source, safety symbols (WHO TRS 1025, Annex 7, 18.28)
8 record itemsnamed for dispatch records, a list that is "not limited to" them, from date of dispatch to batch number and expiry date (18.34)
Not recommendedrepackaging and relabelling, unless done by an authorized entity under GMP (18.11)

Which guidance sets the packaging and labelling expectations?

The main international reference is WHO Technical Report Series No. 1025, Annex 7, Good storage and distribution practices for medical products, Fifty-fourth report (2020).1 Section 18 covers distribution and transport, dispatch, transportation, and repackaging and relabelling.

The starting point, in paragraph 18.13, is that medical products should be transported in accordance with the conditions stated on the labels and described by the manufacturer, and that the risk to quality during transport and distribution should be eliminated or minimized to an acceptable level.1

What should a shipping container label show?

Enough for anyone handling the box to treat it correctly. Paragraph 18.28 of Annex 7 says shipment containers should be labelled indicating, for example, handling and storage conditions, precautions, contents and source, and safety symbols, as appropriate.1

The same paragraph sets the standard for the container itself. Shipment containers should have no adverse effect on the quality of the medical products and should offer adequate protection to materials and these products.1 Paragraph 18.29 adds that special care should be taken when using dry ice and liquid nitrogen in shipment containers, owing to safety issues and possible adverse effects on product quality.1

What belongs on the product label itself?

The glossary in section 3 of Annex 7 describes labelling as the process of identifying a medical product, including, as appropriate: the name of the product; the active ingredient or ingredients, type and amount; the batch number; the expiry date; special storage conditions or handling precautions; directions for use, warnings and precautions; and the names and addresses of the manufacturer and/or supplier.1

How is product and batch identity kept through transit?

By keeping it intact at every step. Paragraph 18.14 says product, batch and container identity should be maintained at all times, and paragraph 18.15 says all labels should remain legible.1

Paragraph 18.39 asks that products be stored and transported under procedures such that the identity of the product is not lost, the product does not contaminate and is not contaminated by other products, adequate precautions are taken against spillage, breakage, misappropriation and theft, and appropriate environmental conditions, such as cold chain for thermolabile products, are maintained.1 Paragraph 18.38 adds that products and shipment containers should be secured to prevent, or to provide evidence of, unauthorized access.1

What dispatch documentation should travel with the shipment?

A documented order, a dispatch record and the appropriate transit documents. Paragraph 18.33 says dispatch and transportation should be undertaken only after receipt of a valid, documented order.1 Paragraph 18.44 says products in transit must be accompanied by the appropriate documentation.1

Paragraph 18.34 says dispatch records should include information such as, but not limited to:1

Paragraph 18.37 of Annex 7 says products should not be supplied so close to expiry that the date is likely to be reached before use; see remaining shelf life at shipment for how buyers set that margin.

Can a shipment be repackaged or relabelled after it arrives?

It is not recommended. Paragraph 18.11 of Annex 7 says repackaging and relabelling of materials and products are not recommended. Where they occur, they should only be performed by entities appropriately authorized to do so, in compliance with the applicable national, regional and international requirements, and in accordance with GMP. Paragraph 18.12 adds that procedures should be in place for the controlled disposal of original packaging, to prevent its reuse.1

What if a container is damaged in transit?

It is recorded, reported and investigated. Paragraph 18.43 says damage to containers and any other event or problem during transit must be recorded and reported to the relevant department, entity or authority and investigated. Paragraph 18.30 calls for written procedures for handling damaged or broken shipment containers, with particular attention to those containing potentially toxic and hazardous products.1

Temperature problems follow the same logic. Paragraph 18.40 says a deviation noticed during transportation should be reported to the supplier, distributor and recipient.1 For what evidence to expect when that happens, see temperature excursions in transit.

How does this apply to shipments for the Republic of Yemen?

The WHO framework above is the international baseline. Any local labelling or documentation requirements for a particular product or consignment are confirmed case by case, and are best raised before the first shipment is packed. For the wider picture, see entering the Yemen market.

Frequently asked questions

What are the packaging and labelling requirements for a pharmaceutical export shipment?

Under WHO Technical Report Series No. 1025, Annex 7, shipment containers should have no adverse effect on product quality and should offer adequate protection. They should be labelled with, for example, handling and storage conditions, precautions, contents and source, and safety symbols, as appropriate. Product, batch and container identity should be maintained at all times, labels should remain legible, and products in transit must carry the appropriate documentation.

What should a dispatch record for medical products include?

WHO Technical Report Series No. 1025, Annex 7, lists the date of dispatch, the full business name, address and contacts of the entity responsible for transport, the status of the addressee, a description of the products, quantities, transport and storage conditions, a unique delivery order number, and the batch number and expiry date. The list is not exhaustive.

Can a pharmaceutical shipment be relabelled after it arrives?

WHO Technical Report Series No. 1025, Annex 7, says repackaging and relabelling are not recommended. Where they do occur, they should only be performed by entities appropriately authorized to do so, in compliance with the applicable national, regional and international requirements and in accordance with GMP. Original packaging should be disposed of under control so it cannot be reused.

What should happen if a shipment container is damaged in transit?

WHO Technical Report Series No. 1025, Annex 7, says damage to containers and any other event or problem during transit must be recorded, reported to the relevant department, entity or authority, and investigated. Written procedures should exist for handling damaged or broken containers, with particular attention to those holding potentially toxic or hazardous products.

References

  1. World Health Organization, Good storage and distribution practices for medical products, WHO Technical Report Series No. 1025, Annex 7, Fifty-fourth report (2020), sections 3 and 18. Accessed 21 October 2026. cdn.who.int